Core Viewpoint - The article discusses the passing of Chinese actress Zhu Yuanyuan and the subsequent spread of false information regarding her will and personal matters, highlighting the ethical issues surrounding the exploitation of public sentiment for personal gain [1][3]. Group 1: Zhu Yuanyuan's Passing - Zhu Yuanyuan, a prominent actress from the National Theatre of China, passed away on May 17, 2025, after a five-year battle with cancer, as announced by her husband Xin Baiqing [5][6]. - The National Theatre of China expressed deep sorrow over her death, acknowledging her contributions to the arts and the impact she had on her colleagues and audiences [1][6]. Group 2: Misinformation and Ethical Concerns - Following her death, various self-media accounts circulated fabricated content, including a false will attributed to Zhu Yuanyuan, which misrepresented her health condition and personal wishes [1][2]. - The dissemination of such misinformation is seen as a violation of the dignity of the deceased and a source of additional pain for the grieving family [3].

Core Viewpoint - The article discusses the passing of renowned actress Zhu Yuanyuan, highlighting her battle with cancer and the impact of her death on the entertainment industry and her colleagues [1][2][12]. Group 1: Zhu Yuanyuan's Life and Career - Zhu Yuanyuan was born on March 18, 1974, in Qingdao, Shandong Province, and was a first-class actress at the National Theatre of China [1][15]. - She dedicated her life to stage and film arts, earning national honors such as the China Television Golden Eagle Award and the Shanghai Film Critics Award for her performances [15]. - Zhu's last completed work was the drama "Zao Cheng Zhe," which she finished shortly before her passing [2][24]. Group 2: Reactions to Her Passing - Following the announcement of her death, many colleagues and friends expressed their shock and sorrow, with numerous tributes shared on social media [2][4][19]. - Notable figures such as Yao Chen and Huang Xiaoming shared heartfelt memories and condolences, reflecting on Zhu's vibrant personality and dedication to her craft [3][4][20]. Group 3: Health and Cancer Awareness - The article touches on the nature of ovarian cancer, referred to as the "king of female cancers," emphasizing its high-risk factors and the importance of early detection [28][29]. - Experts recommend regular screenings for women over 40, as most ovarian cancer cases occur in this age group, highlighting the need for increased awareness and preventive measures [28][29].

Core Viewpoint - The company has a substantial reserve of series projects and has signed multiple cultural tourism contracts, with several major films expected to be released during the summer season, leading to a continued rapid growth in revenue [1] Group 1: Investment Highlights - The company is building a foundation with series and cultural tourism, while films provide performance elasticity. In 2025, the company has a large number of series in reserve, with some top series already recommended by major video platforms like Mango TV. The cultural tourism business, based on three operational scenic spots, has signed multiple new projects, which are expected to bring stable revenue growth. However, the film business, which began to ramp up in 2021, has underperformed, with several films like "Lion Boy 2" failing to achieve expected box office results, negatively impacting the company's performance. As a result, the EPS forecast for 2025-2027 has been revised down to 0.15/0.19/0.22 yuan, compared to the previous forecast of 0.47/0.55 yuan for 2025/2026. The target price has been adjusted to 6.90 yuan from 7.84 yuan, while maintaining a "buy" rating [2][3][4] Group 2: Series and Film Releases - 2025 is expected to be a significant year for the company in terms of series, with nearly ten series anticipated to be aired. According to the company's 2024 annual report, series expected to be released in 2025 include "Criminal Scene" (aired on February 20, 2025), "Silent Echo," "Ordinary Heroes," "Synthesis Order," "Happy," "Mars Orphan," "City Builders," "Hunting Heart," and "Salted Fish Ascension." The company has also announced a change in funding allocation, redirecting 85.44 million yuan initially intended for the film "Space Spring Transportation" to the series "Salted Fish Ascension," indicating its importance. The revenue from confirmed series in 2024 exceeded 400 million yuan, and if the aforementioned series are released in 2025, the company’s series revenue is expected to achieve year-on-year growth [3][4] Group 3: Cultural Tourism Business - Major films are expected to be released within the year, and the cultural tourism business is progressing steadily. According to the company's 2024 annual report, the main films in reserve include "Dunhuang Heroes," "Gate of the Desert," "Bright Future," "Lying Flat Club," and "Story of X," which have completed filming and are in post-production and review stages, suggesting they are likely to be released in 2025. In addition to the three operational districts "Yongxing Fang," "Chang'an Twelve Hours," and "Xiangyang Guanjia Lane," new contracts have been signed for projects in Jiangsu Zhouzhuang, Guilin Lashan, Xiangyang Tiefo Temple, Daliang Qinghui Garden, and Anyang Kuixing Pavilion, which are expected to become important growth points for the company outside of its film and television content [4]

Core Viewpoint - The news highlights the sudden passing of actress Zhu Yuanyuan, who was admired for her resilience and warmth during her battle with cancer, leaving a lasting impact on her family and fans [1][4]. Group 1: Personal Life and Legacy - Zhu Yuanyuan was born in March 1974 in Qingdao, Shandong, and her childhood experiences instilled in her a sense of resilience that characterized her life and career [4]. - She had a long-lasting relationship with her university classmate Xin Baiqing, marrying in 2006 after 14 years of dating, and they had one daughter together [5]. - Zhu Yuanyuan's husband expressed in her obituary that she taught them how to face fate with laughter, a testament to her enduring spirit [5]. Group 2: Career Achievements - Zhu Yuanyuan gained recognition for her role as Li Yunfang in "The Happy Life of Pianzui Zhang Damin," winning multiple awards including the 18th China TV Golden Eagle Award for Most Popular Actress [4]. - She achieved the status of a "Grand Slam" actress by winning Best Actress and Best Supporting Actress awards at the Golden Rooster and Hundred Flowers Awards, showcasing her versatility [4]. - Her recent works included the drama "The City Builder," and she continued to engage with her craft even during her illness, demonstrating her dedication to her artistic ideals [4]. Group 3: Impact on Family and Community - Zhu Yuanyuan's acceptance speech at the 34th Golden Rooster Awards emphasized the importance of balancing career aspirations with family responsibilities, resonating with many parents [7]. - She expressed that her achievements were not just personal victories but also a way to inspire her daughter, showing that a mother can shine in her career while being a nurturing figure [5][7]. - Her ability to connect with audiences through her performances and personal experiences created a deep emotional resonance, making her a beloved figure in the industry [6][7].